seizures
Five Facts about epilepsy
August 21, 2025Medical Communications Five Facts, Neurology, epilepsy, neurological condition, seizures
1 Epilepsy occurs when the normal electrical activity in the brain changes. For many, the cause is unclear, but genes …
MHRA designates cenobamate as a Promising Innovative Medicine for treating drug resistant seizures
August 13, 2020Research and Development MHRA, cenobamate, seizures
Arvelle Therapeutics has announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has given their anti-seizure medication (cenobamate) …
Novartis drug Afinitor significantly reduces seizures in TSC patients
April 21, 2016Research and Development Afinitor, Novartis, Tuberous Sclerosis Complex, drug, seizure, seizures, tsc
Novartis (SIX: NOVN) has announced the results from a Phase III clinical trial which shows that Afinitor (everolimus) significantly reduced …
FDA withdraws approval for Sun Pharma’s epilepsy drug
September 29, 2015Manufacturing and Production Elepsia, FDA, Sun Pharma, epilepsy, levetiracetam, manufacturing, productions, seizures
Manufacturing problems at Sun Pharma’s production site has led the FDA to revoke the company’s approval for Elepsia XR for …
EMA grants first paediatric use marketing authorisation
September 9, 2011Sales and Marketing Buccolam, PUMA, Viropharma, paediatric trials, seizures
The first children’s medicine to hold a new paediatric use marketing authorisation (PUMA), making it available for children only, has …
Encouraging data for Eisai epilepsy drug
August 24, 2010Sales and Marketing Eisai, epilepsy, perampanel, phase III, seizures, study 306
A new phase III study for Eisai’s perampanel (E2007) suggests the first-in-class treatment is effective as an adjunctive treatment of …
Latest content
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
